Pleural fibrosis.
Pleural fibrosis can result from a variety of inflammatory processes. The response of the pleural mesothelial cell to injury and the ability to maintain its integrity are crucial in determining whether normal healing or pleural fibrosis occurs. The pleural mesothelial cell, various cytokines, and disordered fibrin turnover are involved in the pathogenesis of pleural fibrosis. The roles of these mediators in producing pleural fibrosis are examined. This article reviews the most common clinical conditions associated with the development of pleural fibrosis. Fibrothorax and trapped lung are two unique and uncommon consequences of pleural fibrosis. The management of pleural fibrosis, including fibrothorax and trapped lung, is discussed.
Jantz
Michael A
MA
Division of Pulmonary and Critical Care Medicine, University of Florida, 1600 SW Archer Road, Room M352, PO Box 100225, Gainesville, FL 32610-0225, USA. jantzma@medicine.ufl.edu
Antony
Veena B
VB
D001195:Asbestosis / Q000473:pathology; D001026:Coronary Artery Bypass / Q000009:adverse effects; D004847:Epithelial Cells / Q000473:pathology / Q000502:physiology; D005337:Fibrin / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D005355:Fibrosis; D006491:Hemothorax / Q000150:complications; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D010994:Pleura / Q000473:pathology*; D010995:Pleural Diseases / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D010998:Pleurisy / Q000150:complications / Q000473:pathology; D014396:Tuberculosis, Pleural / Q000150:complications / Q000473:pathology
D010982:Platelet-Derived Growth Factor; D016222:Fibroblast Growth Factor 2; D005337:Fibrin